Investment Column: De La Rue, Holidaybreak, Plant Impact

Our view: Buy

Share price: 840p (+10p)

Banknote company De La Rue may have a licence to print money, but after a volatile 12 months the shares have not been quite such a sure thing.

The group released its full-year results yesterday with pre-tax profits beating analysts' expectations, up 10 per cent to £33m. The dividend was maintained, which should have calmed a few nerves among investors after what has been a trying year.

Shares tumbled in August after the company revealed production problems at a paper mill in Hampshire and found falsified specification test certificates. The principal problem with production is believed to be have been related to a key customer, the Reserve Bank of India, and talks over resuming the contract, which was halted at the time, are ongoing.

The chief executive subsequently quit, and yesterday De La Rue's new boss revealed that he had drawn up plans to overhaul the business.

The so-called "improvement plan" intends to lift profits to over £100m within three years by boosting revenues and slashing £30m of costs, which will include job cuts. As Numis pointed out, should the new team reach this target, it would be trading on a price of just 11.5 times full-year earnings for 2014 from 34.7 times for the 2011 financial year.

Late last year, the plunging share price was salvaged as news emerged that De La Rue was a takeover target, but then it tanked once again when French group Oberthur walked away in January, taking its 935p per share offer with it.

Despite failing to land a deal, which De La Rue management said "significantly undervalued the company and its prospects", Oberthur is still lurking and could well return to the table with a bid offering a juicy premium to the current share price.

Beyond that, there is the recovery strategy and "an encouraging order-book profile and a good pipeline of opportunities", according to new chief executive Tom Cobbold. Add the nice 5.1 per cent yield, and we think this one might finally be worth buying into.


Our view: Buy

Share price: 269.5p (+29.5p)

Holidaybreak, the education and activity travel group, was a popular destination for investors yesterday, despite its first-half losses widening.

Shares took off, in part because of a strong pipeline of bookings at its PGL outdoor activity business for schoolchildren. Investors also saluted Holidaybreak's bullishness on the growth potential of Meininger, the Germany-based student tour accommodation group, in which it took a 50 per cent stake last year for £30.8m.

The group posted a £19.2m pre-tax loss for the six months to 31 March, compared with losses of £17.7m the previous year. This was partly the result of geopolitical unrest in the Middle East and North Africa, as well as "difficult trading conditions" for its hotel business.

But we would highlight that Holidaybreak said its educational division is 99 per cent booked for 2011, including near-full capacity at PGL's UK outdoor education centres.

Equally pleasing, we believe, was that Meininger's revenues are up 16 per cent on last year and the business is adding 23 per cent more beds to 4,550. Moreover, Holidaybreak now trades on a forward earnings ratio of under seven times, which now looks attractive. While the holiday sector is a risky one and subject to major external turbulence, we think that Holidaybreak is worth a punt.

Plant Impact

Our view: buy

Share price: 32.5p (+7p)

When a warning on bigger-than- expected losses prompts a stock to move over 25 per cent, it tends to be heading south.

But Plant Impact's announcement yesterday that the agrochemical company has not yet received an expected milestone payment of £0.5m from its BugOil insecticide, thus enlarging the likely loss for the year, appeared to have the opposite effect, with the AIM-listed group seeing a share-price spike.

That is because it came alongside news of a tie-up with Arysta LifeScience or ALS, which will see the Japanese company take a nearly 10 per cent stake. ALS is the world's biggest privately held crop protection and life science group and will be buying shares at 45p a pop, a significant premium. Crucially, in our view, ALS also entered into two commercial agreements, one for the US and the other for Brazil. This is positive, and more than enough reason to buy.

Start your day with The Independent, sign up for daily news emails
Life and Style
A monstrous idea? Body transplants might no longer be science fiction
Science An Italian neurosurgeon believes so - and it's not quite as implausible as it sounds, says Steve Connor
Demba Ba (right) celebrates after Besiktas win on penalties
footballThere was no happy return to the Ataturk Stadium, where the Reds famously won Champions League
Arts and Entertainment
Natural beauty: Aidan Turner stars in the new series of Poldark
arts + ents
Mia Freedman, editorial director of the Mamamia website, reads out a tweet she was sent.
arts + ents
Arts and Entertainment
The write stuff: masters of story-telling James Joyce, left, and Thomas Hardy
arts + ents...begging to differ, John Walsh can't even begin to number the ways
Image from a flyer at the CPAC event where Nigel Farage will be speaking
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Telesales / Marketing Executive - B2B - OTE £25,000

£17000 - £25000 per annum: Recruitment Genius: An opportunity to join this new...

SThree: Trainee Recruitment Consultant

£18000 - £21000 per annum + OTE £45,000: SThree: SThree Group have been well e...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Recruitment Genius: Business Control Manager

£36000 - £44000 per annum: Recruitment Genius: Encouraging more businesses to ...

Day In a Page

HIV pill: Scientists hail discovery of 'game-changer' that cuts the risk of infection among gay men by 86%

Scientists hail daily pill that protects against HIV infection

Breakthrough in battle against global scourge – but will the NHS pay for it?
How we must adjust our lifestyles to nature: Welcome to the 'Anthropocene', the human epoch

Time to play God

Welcome to the 'Anthropocene', the human epoch where we may need to redefine nature itself
MacGyver returns, but with a difference: Handyman hero of classic 1980s TV series to be recast as a woman

MacGyver returns, but with a difference

Handyman hero of classic 1980s TV series to be recast as a woman
Tunnel renaissance: Why cities are hiding roads down in the ground

Tunnel renaissance

Why cities are hiding roads underground
'Backstreet Boys - Show 'Em What You're Made Of': An affectionate look at five middle-aged men

Boys to men

The Backstreet Boys might be middle-aged, married and have dodgy knees, but a heartfelt documentary reveals they’re not going gently into pop’s good night
Crufts 2015: Should foreign dogs be allowed to compete?

Crufts 2015

Should foreign dogs be allowed to compete?
10 best projectors

How to make your home cinema more cinematic: 10 best projectors

Want to recreate the big-screen experience in your sitting room? IndyBest sizes up gadgets to form your film-watching
Manchester City 1 Barcelona 2 player ratings: Luis Suarez? Lionel Messi? Joe Hart? Who was the star man?

Manchester City vs Barcelona player ratings

Luis Suarez? Lionel Messi? Joe Hart? Who was the star man at the Etihad?
Arsenal vs Monaco: Monaco - the making of Gunners' manager Arsene Wenger

Monaco: the making of Wenger

Jack Pitt-Brooke speaks to former players and learns the Frenchman’s man-management has always been one of his best skills
Cricket World Cup 2015: Chris Gayle - the West Indies' enigma lives up to his reputation

Chris Gayle: The West Indies' enigma

Some said the game's eternal rebel was washed up. As ever, he proved he writes the scripts by producing a blistering World Cup innings
In Ukraine a dark world of hybrid warfare and murky loyalties prevails

In Ukraine a dark world of hybrid warfare

This war in the shadows has been going on since the fall of Mr Yanukovych
'Birdman' and 'Bullets Over Broadway': Homage or plagiarism?

Homage or plagiarism?

'Birdman' shares much DNA with Woody Allen's 'Bullets Over Broadway'
Broadchurch ends as damp squib not even David Tennant can revive

A damp squib not even David Tennant can revive

Broadchurch, Series 2 finale, review
A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower: inside the mansion of Germany's 'Bishop of Bling'

Inside the mansion of Germany's 'Bishop of Bling'

A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower